Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma

Clicks: 147
ID: 270231
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Diffuse midline glioma (DMG) is an incurable malignancy with the highest mortality rate among pediatric brain tumors. While radiotherapy and chemotherapy are the most common treatments, these modalities have limited promise. Due to their diffuse nature in critical areas of the brain, the prognosis o …
Reference Key
g2021ebiomedicinecurrent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Price G;Bouras A;Hambardzumyan D;Hadjipanayis CG;;
Journal ebiomedicine
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34157482
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine pmid:34157482 pmc8220552 doi:10.1016/j.ebiom.2021.103453 gabrielle price alexandros bouras constantinos g hadjipanayis brain stem neoplasms / genetics brain stem neoplasms / immunology* brain stem neoplasms / therapy diffuse intrinsic pontine glioma / genetics diffuse intrinsic pontine glioma / immunology* diffuse intrinsic pontine glioma / therapy immunotherapy / methods* tumor microenvironment / immunology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.